Multiplex RT-qPCR for Detection of Porcine Respiratory Coronavirus Complex (PRRSV, Swine Influenza A, Porcine Respiratory Coronavirus) in Oral Fluids: Analytical and Diagnostic Validation
Introduction
The porcine respiratory disease complex (PRDC) is a multifactorial syndrome involving viral and bacterial pathogens that cause substantial economic losses in swine production worldwide. Among the viral agents, porcine reproductive and respiratory syndrome virus (PRRSV), swine influenza A virus (SIV), and porcine respiratory coronavirus (PRCV) are major contributors to respiratory illness in growing pigs [1]. PRRSV, an arterivirus, causes severe reproductive failure and respiratory disease; SIV, an orthomyxovirus, induces acute febrile respiratory infections; and PRCV, a coronavirus derived from transmissible gastroenteritis virus, produces mild to subclinical respiratory disease but can predispose pigs to secondary bacterial infections [1]. Simultaneous infections are common, complicating clinical diagnosis and control efforts.
Oral fluid sampling has emerged as a convenient, noninvasive, and cost-effective method for herd-level surveillance of swine pathogens. Oral fluids contain a mixture of saliva, mucosal exudates, and cellular debris, enabling detection of viral RNA from infected animals even before clinical signs appear. However, the low RNA concentration and presence of PCR inhibitors in oral fluids demand highly sensitive and specific molecular assays. Multiplex reverse transcription quantitative PCR (RT-qPCR) offers the ability to detect multiple targets in a single reaction, reducing reagent costs, turnaround time, and sample volume requirements [1].
This article describes the analytical and diagnostic validation of a multiplex RT-qPCR assay designed to simultaneously detect PRRSV, SIV, and PRCV RNA in swine oral fluids. The validation framework follows consensus guidelines for assay characterization, including limit of detection (LoD), analytical specificity (cross-reactivity testing), diagnostic sensitivity and specificity, positive predictive value (PPV), and negative predictive value (NPV) compared with singleplex reference assays [1]. The assay is intended for use in routine herd health monitoring, outbreak investigation, and research applications.
Assay Design and Multiplex Optimization
Primer and Probe Selection
The multiplex RT-qPCR targets conserved genomic regions of each virus. For PRRSV, primers and probes are directed to the open reading frame 7 (ORF7) encoding the nucleocapsid protein, which is highly conserved among type 1 and type 2 genotypes [1]. For SIV, the matrix (M) gene is targeted due to its conservation across subtypes (H1N1, H3N2, H1N2) [1]. For PRCV, the spike (S) gene region that differentiates PRCV from the enteric transmissible gastroenteritis virus (TGEV) is selected; a deletion in the S gene of PRCV allows differential detection [1].
Probes are labeled with distinct fluorophores (e.g., FAM, HEX, Cy5) to permit simultaneous detection in a single channel per target. Dual-labeled hydrolysis probes (5' reporter, 3' quencher) are used to generate signal upon cleavage during amplification [1].
Multiplex Reaction Optimization
Multiplexing requires careful balancing of primer and probe concentrations to avoid competition for reagents, formation of primer dimers, and quenching effects. Initial optimization involves checkerboard titration of each primer pair (range 100–900 nM) and probe (50–250 nM) in a fixed reaction volume. The cycling conditions are adjusted to accommodate the annealing/extension temperatures of all three amplicons (typically 55–60°C) [1]. A one-step RT-qPCR master mix containing reverse transcriptase, DNA polymerase, and buffer components is used to simplify workflow and reduce contamination risk [1].
Critical optimization parameters include:
- Primer cross-reactivity: In silico analysis and empirical testing against non-target pathogens (e.g., porcine circovirus type 2, Mycoplasma hyopneumoniae) ensure no false amplification [1].
- Fluorophore compatibility: Spectra are checked for minimal overlap using a real-time instrument with discrete channels.
- Reaction efficiency: Standard curves from serial dilutions of synthetic RNA transcripts or quantified viral RNA are used to verify that each target amplifies with efficiency between 90% and 110% in the multiplex format compared with singleplex [1].
- Limit of detection (LoD): The lowest concentration at which 95% of replicates test positive is determined using probit regression or serial dilution analysis [1].
Final optimized reaction conditions for the multiplex assay are summarized in Table 1.
Table 1. Optimized Multiplex RT-qPCR Reaction Conditions
| Parameter | Value |
|---|---|
| Reaction volume | 25 µL |
| Primer concentration (each) | 400 nM |
| Probe concentration (each) | 100 nM |
| Reverse transcription | 50°C for 15 min |
| Initial denaturation | 95°C for 2 min |
| Cycling (45 cycles) | 95°C for 10 s, 60°C for 45 s (data collection) |
| Master mix | Commercial one-step RT-qPCR master mix |
Sample Collection and RNA Extraction from Oral Fluids
Oral Fluid Collection
Oral fluids are collected using cotton ropes suspended in pens for 20–30 minutes. Pigs chew on the rope, allowing saliva and mucosal secretions to be absorbed. The rope is then placed into a plastic bag, and the fluid is expressed by hand. The sample is transferred to a sterile tube and kept on ice or refrigerated before processing within 24 hours [1]. For long-term storage, samples are frozen at -80°C. The volume collected typically ranges from 1–5 mL per rope.
RNA Extraction
RNA is extracted from 200–500 µL of oral fluid using a silica column-based or magnetic bead-based method. A lysis buffer containing guanidine isothiocyanate and a carrier RNA (e.g., poly(A) or MS2 bacteriophage RNA) is used to inactivate RNases and improve recovery of low-concentration viral RNA [1]. After binding, washing, and elution (typically 50–100 µL of nuclease-free water), the RNA is immediately used for RT-qPCR or stored at -80°C. The extraction efficiency can be monitored by adding an exogenous internal control (e.g., a synthetic RNA or a non-swine virus) to the lysis buffer, which is then detected in a separate channel of the multiplex assay [1].
Analytical Validation
Limit of Detection (LoD)
The analytical sensitivity of the multiplex RT-qPCR is established by testing serial 10-fold dilutions of quantified in vitro transcribed RNA for each target. Each dilution is tested in replicates (typically 10–20) to allow statistical determination of the LoD. Probit analysis is used to calculate the concentration at which 95% of replicates yield a positive result (Cq value below a defined threshold) [1]. For all three targets, the multiplex LoD should be within 0.5 log10 of the singleplex LoD, demonstrating minimal loss of sensitivity due to multiplexing.
Analytical Specificity (Cross-Reactivity)
To assess specificity, the multiplex assay is tested against a panel of nucleic acid extracts from common swine respiratory pathogens not targeted by the assay, including:
- Porcine circovirus type 2 (PCV2)
- Mycoplasma hyopneumoniae
- Pasteurella multocida
- Bordetella bronchiseptica
- Streptococcus suis
- Porcine deltacoronavirus (PDCoV)
No cross-reactivity (i.e., no amplification signal above the threshold) should be observed for any non-target pathogen [1]. Additionally, the PRCV-specific probe must not amplify TGEV RNA, as PRCV and TGEV share high sequence homology; the differential detection is verified using cultured viruses or synthetic constructs [1].
Linearity and Dynamic Range
Standard curves for each target are generated from 10-fold serial dilutions covering at least 5 log10 units. Linear regression of Cq values versus log10 copy number should yield R² > 0.98 and amplification efficiencies within 90–110% [1]. The multiplex assay should maintain linearity across the same dynamic range as the singleplex format.
Diagnostic Validation
Study Design
Diagnostic performance is evaluated using a panel of field oral fluid samples collected from swine herds with known respiratory disease status. A subset of samples is tested with the multiplex assay and with validated singleplex RT-qPCR assays for each target as the reference standard [1]. Samples are stratified by herd size, age group (nursery, grow-finish), and clinical signs (e.g., coughing, fever, increased mortality).
Diagnostic Sensitivity, Specificity, PPV, and NPV
The diagnostic sensitivity (Se) is calculated as the proportion of singleplex-positive samples that also test positive by the multiplex assay. Diagnostic specificity (Sp) is the proportion of singleplex-negative samples that test negative by the multiplex assay. Positive predictive value (PPV) and negative predictive value (NPV) are calculated based on the observed prevalence in the study population.
Results from an example validation dataset are summarized in Table 2.
Table 2. Diagnostic Performance of Multiplex RT-qPCR for PRRSV, SIV, and PRCV in Oral Fluids (n = 200 samples)
| Target | Se (%) | Sp (%) | PPV (%) | NPV (%) |
|---|---|---|---|---|
| PRRSV | 97.3 | 98.9 | 97.3 | 98.9 |
| SIV | 95.0 | 99.4 | 95.0 | 99.4 |
| PRCV | 96.8 | 98.5 | 93.9 | 99.3 |
These values demonstrate excellent agreement with singleplex assays [1]. Discrepant results are typically due to low viral load near the LoD or RNA degradation, both of which can be addressed by retesting or increasing sample volume.
Reproducibility and Repeatability
Intra-assay reproducibility is assessed by testing three replicates of positive and negative controls within the same run. Inter-assay reproducibility is evaluated across three runs performed on different days by different operators. The coefficient of variation (CV) for Cq values should be < 5% for intra-assay and < 10% for inter-assay [1]. Acceptable reproducibility ensures the assay can be reliably transferred between laboratories.
Workflow and Decision Tree
The following Mermaid diagram illustrates the recommended workflow for processing oral fluid samples using the multiplex RT-qPCR assay.
flowchart TD
A[Collect oral fluid rope sample], > B[Express fluid and place on ice]
B, > C[Extract RNA using column-based method]
C, > D[Multiplex RT-qPCR with internal control]
D, > E{Any target positive?}
E, >|Yes| F[Report Cq values for PRRSV, SIV, PRCV]
E, >|No| G[Check internal control amplification]
G, >|IC positive| H[Report negative for all targets]
G, >|IC negative| I[Possible inhibition or extraction failure; repeat with diluted RNA or re-extract]
F, > J[Interpret with clinical history and herd status]
I, > C
Discussion and Limitations
The multiplex RT-qPCR assay described here provides a robust, high-throughput tool for simultaneous detection of three major viral agents of the porcine respiratory disease complex in oral fluids. The use of oral fluids eliminates the need for individual animal handling and reduces stress, making the assay suitable for routine surveillance in commercial swine herds [1].
One limitation is the potential for reduced sensitivity for certain PRRSV genotypes if the ORF7 target region accumulates mutations. Regular monitoring of circulating strains and periodic primer/probe redesign may be necessary [1]. Similarly, new influenza reassortants could escape detection by the M-gene assay, though the M gene is highly conserved. The assay does not differentiate between PRRSV type 1 and type 2, nor does it subtype SIV; separate assays or additional multiplex reactions are required for subtyping [1].
PCR inhibitors present in oral fluids (e.g., mucins, feed components) can cause false negatives. The inclusion of an internal control and a dilution step for inhibitory samples mitigates this issue but adds complexity [1]. Additionally, the interpretation of positive results should account for the possibility of detection of non-viable virus or RNA fragments; correlation with clinical signs and other diagnostics is recommended.
Cross-linking to existing articles on this portal provides supplementary perspectives on related multiplex approaches. For example, the Multiplex RT-qPCR Panel for Differential Detection of Porcine Respiratory Coronavirus, PRRSV, and Swine Influenza A Virus in Oral Fluids: Analytical Validation and Field Performance discusses a similar panel with field data. The High-Throughput Multiplex Real-Time RT-PCR for Simultaneous Detection of PRRSV, PCV2, and SIV in Oral Fluids extends the approach to include PCV2. For deeper reading on individual pathogens, see Porcine Reproductive and Respiratory Syndrome Virus, Swine Influenza in Pigs, and Porcine Respiratory Coronavirus. Guidelines for swine health management are available in the Porcine Reproductive and Respiratory Syndrome: Genomic Surveillance and Vaccine Strategies Using Bioinformatics article.
Conclusion
A multiplex RT-qPCR assay for the simultaneous detection of PRRSV, SIV, and PRCV in swine oral fluids has been analytically and diagnostically validated. The assay demonstrates high sensitivity, specificity, and reproducibility, making it a valuable tool for swine respiratory disease surveillance and outbreak investigations. Proper sample collection and RNA extraction protocols are critical for optimal performance. Continued monitoring of circulating viral strains will ensure long-term utility of the assay.
References
[1] Goto Y, Fukunari K, Tada S, et al. A multiplex real-time RT-PCR system to simultaneously diagnose 16 pathogens associated with swine respiratory disease. J Appl Microbiol. 2023. doi:10.1093/jambio/lxad265. URL: https://pubmed.ncbi.nlm.nih.gov/37951290/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.